GlobeNewswire: Rising Biosciences, Inc. Contains the last 10 of 11 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T06:38:15ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2019/06/04/1863944/0/en/Rising-Biosciences-Inc-Acquires-SNB-Health-Signs-Contract-to-Purchase-40-000-Sq-Ft-Facility-for-Behavioral-Health-Addiction-Treatment-Inpatient-Center.html?f=22&fvtc=4&fvtv=44201Rising Biosciences Inc. Acquires SNB Health, Signs Contract to Purchase 40,000 Sq. Ft. Facility for Behavioral Health Addiction Treatment Inpatient Center2019-06-04T12:35:00Z<![CDATA[SANDUSKY, Ohio, June 04, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE — Rising Biosciences, Inc. (OTC: RBII) is pleased to announce the recent acquisition of Southern Northern Behavioral Health, Inc. (SNB Health) a growing substance abuse treatment company, as a wholly owned subsidiary. In conjunction with the acquisition, Rising Biosciences has signed a contract to purchase a 40,000 square foot former recreation facility that will be renovated for use as a behavioral health inpatient center for the purpose of treating all types of substance abuse including opioid addiction, alcohol abuse and related mental health issues.]]>RBII PR June 3CANNOPHEN https://www.globenewswire.com/news-release/2019/03/08/1750742/0/en/Rising-Biosciences-Inc-Announces-New-Partnership-in-Addition-to-Naming-New-COO.html?f=22&fvtc=4&fvtv=44201Rising Biosciences Inc. Announces New Partnership in Addition to Naming New COO2019-03-08T16:23:03Z<![CDATA[SANDUSKY, Ohio, March 08, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE - - Rising Biosciences Inc. (OTC: RBII), a research development pharmaceutical and physicians practice management company, is pleased to announce a new partnership with Three Seven Management in addition to naming Christopher Will as the new COO of RBII.]]>https://www.globenewswire.com/news-release/2018/11/07/1647425/0/en/CORRECTION-Rising-Biosciences-Set-To-Acquire-All-Assets-from-PAO-Group-Announces-Management-Change.html?f=22&fvtc=4&fvtv=44201(CORRECTION) Rising Biosciences Set To Acquire All Assets from PAO Group / Announces Management Change2018-11-07T21:07:57Z<![CDATA[SANDUSKY, Ohio, Nov. 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Rising Biosciences, Inc. (OTC: RBII) ("RBII" "the Company"), a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry and the FDA, is pleased to announce that the Company has reached an agreement with PAO Group (OTC: PAOG) to acquire all current assets including PAO's medical clinics located in Florida, Pennsylvania and Ohio.]]>https://www.globenewswire.com/news-release/2018/11/07/1647323/0/en/Rising-Biosciences-Set-To-Acquire-All-Assets-from-PAO-Group.html?f=22&fvtc=4&fvtv=44201Rising Biosciences Set To Acquire All Assets from PAO Group2018-11-07T20:29:23Z<![CDATA[SANDUSKY, Ohio, Nov. 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Rising Biosciences, Inc. (OTC : RBII) ("RBII" "the Company"), a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry and the FDA, is pleased to announce that the Company has reached an agreement with PAO Group (OTC: PAOG) to acquire all current assets including PAO's medical clinics located in Florida, Pennsylvania and Ohio.]]>https://www.globenewswire.com/news-release/2018/10/10/1619236/0/en/Rising-Biosciences-Receives-FDA-Clearance-for-TSW-Pain-Cream-Expedites-Testing-of-CBD-Only-Variants-of-Cannophen-and-TSW-Pain-Cream-Products.html?f=22&fvtc=4&fvtv=44201Rising Biosciences Receives FDA Clearance for TSW Pain Cream; Expedites Testing of CBD Only Variants of Cannophen™ and TSW Pain Cream Products2018-10-10T12:30:00Z<![CDATA[RBII Seeks Corporate Registration in Canada Alongside Country’s Decision to Legalize Marijuana]]>$RBII FDA APPROVALAnalyses Biologiques et Chimiques$RBII FDA APPROVALAnalyses Biologiques et Chimiques$RBII FDA APPROVALAnalyses Biologiques et Chimiques$RBII FDA APPROVALAnalyses Biologiques et Chimiques$RBII FDA APPROVALAnalyses Biologiques et Chimiques$RBII FDA APPROVALAnalyses Biologiques et Chimiques$RBII FDA APPROVALAnalyses Biologiques et Chimiques$RBII FDA APPROVALAnalyses Biologiques et Chimiqueshttps://www.globenewswire.com/news-release/2018/07/02/1532509/0/en/Rising-Biosciences-Launches-RBS0346-Clinical-Strength-Dulcis-Stem-Cell-Cream-on-Amazon-Advancements-in-FDA-Approvals-Indicate-Bright-Future-for-Cannophen.html?f=22&fvtc=4&fvtv=44201Rising Biosciences Launches RBS0346 Clinical Strength Dulcis Stem Cell Cream on Amazon; Advancements in FDA Approvals Indicate Bright Future for Cannophen™2018-07-02T15:00:18Z<![CDATA[SANDUSKY, Ohio, July 02, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Rising Biosciences, Inc. (RBII) (“RBII” “the Company”), a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, is pleased to announce that its revolutionary RBS0346 Clinical Strength Dulcis Stem Cell Cream will be available on Amazon.com in the coming days.]]>Recreational, medical and CBD by stateMarijuana legalization by statehttps://www.globenewswire.com/news-release/2018/06/11/1519876/0/en/Rising-Biosciences-Anticipates-Products-on-MMJ-Dispensary-Shelves-in-Late-September-2018.html?f=22&fvtc=4&fvtv=44201Rising Biosciences Anticipates Products on MMJ Dispensary Shelves in Late September 20182018-06-11T17:24:21Z<![CDATA[RBII to Contract with Producers/Processors in MMJ States to License and Market Cannophen™, THC Products]]>https://www.globenewswire.com/news-release/2018/05/01/1494289/0/en/Rising-Biosciences-Announces-Official-Sales-and-Distribution-of-its-RSB0238-Clinical-Strength-Peptide-Complex-on-Amazon.html?f=22&fvtc=4&fvtv=44201Rising Biosciences Announces Official Sales and Distribution of its RSB0238 Clinical Strength Peptide Complex on Amazon®2018-05-01T17:26:22Z<![CDATA[RSII’s serum ranks among top best-sellers in its category]]>$RSII RSB0238 Clinical Strength Peptide Complex now available on Amazon.com! RSB0238 Clinical Strength Peptide Complexhttps://www.globenewswire.com/news-release/2018/03/20/1443055/0/en/Rising-Biosciences-Expedites-Growth-Expansion-with-In-House-Chemist-Laboratory-Analytical-Equipment-and-Producer-Processor-Contracts.html?f=22&fvtc=4&fvtv=44201Rising Biosciences Expedites Growth/Expansion with In-House Chemist, Laboratory Analytical Equipment and Producer/Processor Contracts2018-03-20T15:53:36Z<![CDATA[SANDUSKY, Ohio, March 20, 2018 (GLOBE NEWSWIRE) -- (via OTC PR WIRE) --Rising India, Inc.’s (OTC:RSII) -- Rising Biosciences, Inc., a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, is pleased to announce that it has launched near-term initiatives to expedite growth for long-term shareholder value.]]>Before and AfterRBS0238 CLINICAL PEPTIDE SERUMReady for ProductionRBS0238 CLINICAL PEPTIDE SERUMhttps://www.globenewswire.com/news-release/2018/02/20/1362025/0/en/Rising-Biosciences-Inc-To-Offer-Cannophen-to-Patients-in-Ohio-Florida-Launches-Initiatives-for-National-Distribution-of-Scar-Peptide-Serum.html?f=22&fvtc=4&fvtv=44201Rising Biosciences, Inc. To Offer Cannophen™ to Patients in Ohio, Florida; Launches Initiatives for National Distribution of Scar Peptide Serum2018-02-20T14:45:00Z<![CDATA[SANDUSKY, Ohio, Feb. 20, 2018 (GLOBE NEWSWIRE) -- (via OTC PR WIRE) -- Rising India, Inc.’s (OTC:RSII) -- Rising Biosciences, Inc., a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, is pleased to announce that it will partner with PAO Group’s (OTC:PAOG) Alternative Medicine Centers of America to offer a free trial of Cannophen™ to patients in the state of Ohio. Anyone with a valid Ohio recommendation can apply for the trial at our Ohio clinics; this will be done on a patient to patient basis.]]>Rising Biosciences Scar Peptide SerumScar Peptide SerumBefore and after surgery using Rising Bioscience’s Scar Peptide Serum to diminish scarsScar Peptide Serum results